KURA

Conviction 60HealthcareScan · Thu, Sep 24, 2026

Kura Oncology, Inc. (KURA) closed at $10.87 (-1.59%) on Sep 24, 2026. Price is below its 50-day and above its 200-day moving average. RSI(14) 40, RS Rating 84, -20.1% from its 52-week high, +5.1% year to date. Sector: Healthcare · PHARMACEUTICAL PREPARATIONS.

KURA$10.87-1.59%

ResistanceSupportVol 14Insider buyInsider sell

Vol MA14 1.96M

Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24

Kura Oncology, Inc.PHARMACEUTICAL PREPARATIONSwww.kuraoncology.com ↗

Price10.87

Change-1.59%

Gap-0.18%

Rel volume1.35×

Avg volume1.92M

Avg $ vol23.03M

SMA 2012.06

SMA 5011.18

SMA 2009.81

Price vs 50-2.78%

Price vs 200+10.79%

MA stackmixed

50/200 cross—

Supertrenddown · 12.62

RSI (14)40

MACD hist-0.19

MACD cross—

Stoch %K / %D8 / 15

ADX (14)20

+DI / −DI21 / 26

RSI divergence—

MACD divergence—

ATR %5.47%

ADR %4.20%

52w high13.59

52w low7.40

From 52w high-20.05%

Above 52w low+46.82%

New 52w highNo

SqueezeOff

Bollinger width25.52%

%B0.11

Donchian pos7.12%

Donchian high13.41

Donchian low10.67

AVWAP (52w high)12.26

vs AVWAP high-11.37%

AVWAP (52w low)10.11

vs AVWAP low+7.49%

OBV trendDown

Chaikin MF (20)-0.16

Today vs 20d1.35×

Avg vol (14d)1.96M

Avg vol (20d)1.92M

Avg $ vol (20d)23.03M

Market cap966.56M

RS Rating84 / 99

RS 3m (vs SPY)+0.38%

RS 6m (vs SPY)+10.26%

RS line new highNo

Trend template7/8

Technical rank62.0

1 week-7.30%

1 month-20.05%

3 months+4.87%

6 months+27.08%

1 year+31.86%

YTD+5.13%

P/E-3.47

P/B19.96

P/S14.32

P/FCF-13.67

EPS-3.18

Div yield—

ROE-575.39%

ROA-47.41%

Debt/Eq0.20

Current4.73

EV/EBITDA—

Gross margin—

Net margin-412.95%

Rev growth25.24%

EPS growth-60.17%

Price target26.46

Target upside143.53%

Analyst ratingBuy

Institutional104.41%

Ent. value906.11M

Revenue20.87M

Net income-68.33M

Gross profit—

Free cash flow-70.7M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out88.77M

Employees260

ListedTue, Aug 25, 2015

Free float78.06M

Float %87.9%

Short interest13.42M

Days to cover4.8d

Short volume74.0%

Squeeze score84 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$0.77 vs −$0.89

Last surprise+13.5% beat

Setup gradeB

Conviction60 / 100

Pattern quality—

Tech rank62.0 / 100

Group rank59 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance13.66

Support9.92

Days since event—

Candle confirm—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in KURA

All disclosures →

No recent disclosed trades by Congress in KURA. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in KURA · open-market 2 buys · 3 sells

Insider	Side	Shares	Value	Traded	Filed
WILSON TROY EDWARD President and CEO · Common Stock · 2026-08-24	Buy	100K	$1.2M	2026-08-24	2026-08-24
Powl Brian T. Chief Commercial Officer · Common Stock · 2026-08-21	Sell	4.34K	$52K	2026-08-21	2026-08-24
Bair Teresa Brophy Chief Legal Officer · Common Stock · 2026-08-19	Sell	31.49K	$398K	2026-08-19	2026-08-21
WILSON TROY EDWARD President and CEO · Common Stock · 2026-08-17	Buy	100K	$1.1M	2026-08-17	2026-08-17
Leoni Mollie Chief Medical Officer · Common Stock · 2026-06-18	Sell	84.93K	$834K	2026-06-18	2026-06-22
Parks Diane L. Director · Option to purchase common stock · 2026-06-04	Grant	35K	$0	2026-06-04	2026-06-04
Collins Helen Louise Director · Option to purchase common stock · 2026-06-04	Grant	35K	$0	2026-06-04	2026-06-04
Malley Thomas Director · Option to purchase common stock · 2026-06-04	Grant	35K	$0	2026-06-04	2026-06-04
Hasnain Faheem Director · Option to purchase common stock · 2026-06-04	Grant	35K	$0	2026-06-04	2026-06-04
VASCONCELLES MICHAEL Director · Option to purchase common stock · 2026-06-04	Grant	35K	$0	2026-06-04	2026-06-04

SEC filings

EDGAR filings in KURA · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.